Cargando…

Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents

BACKGROUND: Influenza affects all age groups and is common in children. Between 15% and 42% of preschool- and school-aged children experience influenza each season. Recently, intranasal live attenuated influenza vaccine, trivalent (LAIV) has been approved in Canada. OBJECTIVE: The objective of this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarride, Jean-Eric, Burke, Natasha, Von Keyserlingk, Camilla, O’Reilly, Daria, Xie, Feng, Goeree, Ron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468276/ https://www.ncbi.nlm.nih.gov/pubmed/23055756 http://dx.doi.org/10.2147/CEOR.S33444

Ejemplares similares

Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application
por: Goeree, Ron, et al.
Publicado: (2011)

A review of health utilities across conditions common in paediatric and adult populations
por: Tarride, Jean-Eric, et al.
Publicado: (2010)

Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma
por: Turner, Paul J., et al.
Publicado: (2020)

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020)

A prospective, double-blind, randomized, controlled clinical trial comparing standard wound care with adjunctive hyperbaric oxygen therapy (HBOT) to standard wound care only for the treatment of chronic, non-healing ulcers of the lower limb in patients with diabetes mellitus: a study protocol
por: O'Reilly, Daria, et al.
Publicado: (2011)

TIV Vaccination Modulates Host Responses to Influenza Virus Infection that Correlate with Protection against Bacterial Superinfection
por: Choi, Angela, et al.
Publicado: (2019)

664 Influenza Vaccination in Chronically Ill Children: Taking a Closer Look at LAIV
por: Merckx, Joanna, et al.
Publicado: (2014)

The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
por: Rose, Markus A, et al.
Publicado: (2014)

Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children
por: Turner, P. J., et al.
Publicado: (2019)

Evaluation of health outcomes in osteoarthritis patients after total knee replacement: a two-year follow-up
por: Xie, Feng, et al.
Publicado: (2010)

Enhanced Potency and Durability of Antibody Response to Seasonal Trivalent Inactivated Influenza Vaccine (TIV) Combined with a Novel Water-in-Oil Adjuvant System at Reduced Hemagglutinin (HA) Doses
por: Gorse, Geoffrey J, et al.
Publicado: (2017)

Effects of study design and trends for EVAR versus OSR
por: Hopkins, Robert, et al.
Publicado: (2008)

Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A Streptococcus (GAS) Infection in England
por: Sinnathamby, Mary A, et al.
Publicado: (2023)

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
por: Blackhouse, Gord, et al.
Publicado: (2010)

Systematic narrative review of decision frameworks to select the appropriate modelling approaches for health economic evaluations
por: Tsoi, B, et al.
Publicado: (2015)

Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada
por: Tarride, Jean-Eric, et al.
Publicado: (2012)

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2018)

An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017
por: Sinnathamby, Mary A., et al.
Publicado: (2023)

Current Opinion in LAIV: A Matter of Parent Virus Choice
por: Kiseleva, Irina
Publicado: (2022)

Should Endovascular Repair Be Reimbursed for Low Risk Abdominal Aortic Aneurysm Patients? Evidence from Ontario, Canada
por: Tarride, Jean-Eric, et al.
Publicado: (2011)

LOCALIZATION OF DNA AND PROTEIN IN TIPULA IRIDESCENT VIRUS (TIV) BY ENZYMATIC DIGESTION AND ELECTRON MICROSCOPY
por: Thomas, Richard S., et al.
Publicado: (1961)

Human immune responses elicited by an intranasal inactivated H5 influenza vaccine
por: Ainai, Akira, et al.
Publicado: (2020)

Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice
por: Hua, Tao, et al.
Publicado: (2022)

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
por: Sobhanie, Mahdee, et al.
Publicado: (2016)

1060 The Effect of Live Attenuated Influenza Vaccine (LAIV) on Bacterial Colonization in Healthy 2-4 Year Old Children. A Randomised Controlled Study
por: Thors, Valtyr, et al.
Publicado: (2014)

Shape-dependent adjuvanticity of nanoparticle-conjugated RNA adjuvants for intranasal inactivated influenza vaccines
por: Tazaki, Taiyu, et al.
Publicado: (2018)

Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada
por: O’Reilly, Daria J, et al.
Publicado: (2018)

Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2–16 years after successive annual vaccinations with LAIV
por: Hoschler, Katja, et al.
Publicado: (2020)

Simulating an emergency department: the importance of modeling the interactions between physicians and delegates in a discrete event simulation
por: Lim, Morgan E, et al.
Publicado: (2013)

985. Safety of Guidelines Recommending LAIV for Routine Use in Children and Adolescents With Asthma
por: Nordin, James, et al.
Publicado: (2018)

Immunity following intranasal administration of an inactivated, freeze-dried A/England/42/72 vaccine
por: Potter, C. W., et al.
Publicado: (1975)

Safety and Viral Shedding of Live Attenuated Influenza Vaccine (LAIV) in Chinese Healthy Juveniles and Adults: A Phase Ⅰ Randomized, Double-Blind, Placebo-Controlled Study
por: Li, Li, et al.
Publicado: (2022)

Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults
por: Ainai, Akira, et al.
Publicado: (2013)

Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada
por: Tarride, Jean-Eric, et al.
Publicado: (2018)

Strategies for intranasal delivery of vaccines
por: Zaman, Mehfuz, et al.
Publicado: (2012)

Cost-Effectiveness of Catheter Ablation for Rhythm Control of Atrial Fibrillation
por: Blackhouse, Gord, et al.
Publicado: (2013)

Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells
por: Shcherbik, Svetlana, et al.
Publicado: (2019)

Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
por: Desheva, Yulia, et al.
Publicado: (2022)

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame
por: Parker, Edward PK, et al.
Publicado: (2015)

High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors
por: Becker, Debbie L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nk8lm8rl4acf2t3f66pjas57t9